Real-world data show higher event rates, likely reflecting selection bias and underreporting in controlled trials
Geographically, Novo is a global player, operating in over 170 countries
Blundell led a small study, published in 2017, that found people taking semaglutide not only reduced their overall daily food intake but also preferred and consumed fewer high-fat and savory foods
All our product candidates that we do not intend to out-license are in the discovery stage, pre-clinical, or clinical development stage
A clear roadmap that helps you avoid the most common buying mistakes whether you are a firsttime user or a seasoned supplement shopper
While standard negligence claims may be part of your case, your attorney will delve into potential product liability issues unique to your situation